Literature DB >> 22543468

Finding the sweet spot: the role of nature and nurture in medicinal chemistry.

Michael M Hann1, György M Keserü.   

Abstract

Given its position at the heart of small-molecule drug discovery, medicinal chemistry has an important role in tackling the well-known productivity challenges in pharmaceutical research and development. In recent years, extensive analyses of successful and failed discovery compounds and drug candidates have improved our understanding of the role of physicochemical properties in drug attrition. Based on the clarified challenges in finding the 'sweet spot' in medicinal chemistry programmes, we suggest that this goal can be achieved through a combination of first identifying chemical starting points with appropriate 'nature' and then rigorously 'nurturing' them during lead optimization. Here, we discuss scientific, strategic, organizational and cultural considerations for medicinal chemistry practices, with the aim of promoting more effective use of what is already known, as well as a wider appreciation of the risks of pursuing suboptimal compounds.

Mesh:

Substances:

Year:  2012        PMID: 22543468     DOI: 10.1038/nrd3701

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  68 in total

1.  Time-related differences in the physical property profiles of oral drugs.

Authors:  Paul D Leeson; Andrew M Davis
Journal:  J Med Chem       Date:  2004-12-02       Impact factor: 7.446

Review 2.  Predicting protein druggability.

Authors:  Philip J Hajduk; Jeffrey R Huth; Christin Tse
Journal:  Drug Discov Today       Date:  2005-12       Impact factor: 7.851

3.  Global mapping of pharmacological space.

Authors:  Gaia V Paolini; Richard H B Shapland; Willem P van Hoorn; Jonathan S Mason; Andrew L Hopkins
Journal:  Nat Biotechnol       Date:  2006-07       Impact factor: 54.908

Review 4.  How many drug targets are there?

Authors:  John P Overington; Bissan Al-Lazikani; Andrew L Hopkins
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

5.  Physiochemical drug properties associated with in vivo toxicological outcomes.

Authors:  Jason D Hughes; Julian Blagg; David A Price; Simon Bailey; Gary A Decrescenzo; Rajesh V Devraj; Edmund Ellsworth; Yvette M Fobian; Michael E Gibbs; Richard W Gilles; Nigel Greene; Enoch Huang; Teresa Krieger-Burke; Jens Loesel; Travis Wager; Larry Whiteley; Yao Zhang
Journal:  Bioorg Med Chem Lett       Date:  2008-07-24       Impact factor: 2.823

Review 6.  Adding calorimetric data to decision making in lead discovery: a hot tip.

Authors:  John E Ladbury; Gerhard Klebe; Ernesto Freire
Journal:  Nat Rev Drug Discov       Date:  2009-12-04       Impact factor: 84.694

7.  Ten key issues in modern flow chemistry.

Authors:  Jens Wegner; Sascha Ceylan; Andreas Kirschning
Journal:  Chem Commun (Camb)       Date:  2011-03-15       Impact factor: 6.222

8.  Assessing the lipophilicity of fragments and early hits.

Authors:  Paul N Mortenson; Christopher W Murray
Journal:  J Comput Aided Mol Des       Date:  2011-05-26       Impact factor: 3.686

9.  Thermodynamics of ligand binding and efficiency.

Authors:  Charles H Reynolds; M Katharine Holloway
Journal:  ACS Med Chem Lett       Date:  2011-03-23       Impact factor: 4.345

10.  BINANA: a novel algorithm for ligand-binding characterization.

Authors:  Jacob D Durrant; J Andrew McCammon
Journal:  J Mol Graph Model       Date:  2011-01-19       Impact factor: 2.518

View more
  94 in total

1.  The importance of molecular complexity in the design of screening libraries.

Authors:  Shahul H Nilar; Ngai Ling Ma; Thomas H Keller
Journal:  J Comput Aided Mol Des       Date:  2013-09       Impact factor: 3.686

2.  Radiolabeled inhibitors as probes for imaging mutant IDH1 expression in gliomas: Synthesis and preliminary evaluation of labeled butyl-phenyl sulfonamide analogs.

Authors:  Satish K Chitneni; Zachary J Reitman; David M Gooden; Hai Yan; Michael R Zalutsky
Journal:  Eur J Med Chem       Date:  2016-04-28       Impact factor: 6.514

3.  An integrated suite of modeling tools that empower scientists in structure- and property-based drug design.

Authors:  Jianwen A Feng; Ignacio Aliagas; Philippe Bergeron; Jeff M Blaney; Erin K Bradley; Michael F T Koehler; Man-Ling Lee; Daniel F Ortwine; Vickie Tsui; Johnny Wu; Alberto Gobbi
Journal:  J Comput Aided Mol Des       Date:  2015-04-29       Impact factor: 3.686

4.  Data quality in drug discovery: the role of analytical performance in ligand binding assays.

Authors:  Hermann Wätzig; Imke Oltmann-Norden; Franziska Steinicke; Hassan A Alhazmi; Markus Nachbar; Deia Abd El-Hady; Hassan M Albishri; Knut Baumann; Thomas Exner; Frank M Böckler; Sami El Deeb
Journal:  J Comput Aided Mol Des       Date:  2015-06-13       Impact factor: 3.686

5.  A desirability function-based scoring scheme for selecting fragment-like class A aminergic GPCR ligands.

Authors:  Ádám A Kelemen; György G Ferenczy; György M Keserű
Journal:  J Comput Aided Mol Des       Date:  2014-10-19       Impact factor: 3.686

Review 6.  Applying thermodynamic profiling in lead finding and optimization.

Authors:  Gerhard Klebe
Journal:  Nat Rev Drug Discov       Date:  2015-01-23       Impact factor: 84.694

7.  Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening.

Authors:  Mária Szaszkó; István Hajdú; Beáta Flachner; Krisztina Dobi; Csaba Magyar; István Simon; Zsolt Lőrincz; Zoltán Kapui; Tamás Pázmány; Sándor Cseh; György Dormán
Journal:  Mol Divers       Date:  2017-01-09       Impact factor: 2.943

Review 8.  Expanding the medicinal chemistry synthetic toolbox.

Authors:  Jonas Boström; Dean G Brown; Robert J Young; György M Keserü
Journal:  Nat Rev Drug Discov       Date:  2018-08-24       Impact factor: 84.694

9.  Anticancer potential of aminomethylidene-diazinanes I. Synthesis of arylaminomethylidene of diazinetriones and its cytotoxic effects tested in glioblastoma cells.

Authors:  Nichole A Pianovich; Mathew Dean; Adam Lassak; Krzysztof Reiss; Branko S Jursic
Journal:  Bioorg Med Chem       Date:  2017-08-12       Impact factor: 3.641

10.  Discovery of O-Alkylamino Tethered Niclosamide Derivatives as Potent and Orally Bioavailable Anticancer Agents.

Authors:  Haijun Chen; Zhengduo Yang; Chunyong Ding; Lili Chu; Yusong Zhang; Kristin Terry; Huiling Liu; Qiang Shen; Jia Zhou
Journal:  ACS Med Chem Lett       Date:  2013-01-15       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.